Who and why; sharing our experiences of developing a standard operating procedure (SOP) to allocate screening slots for highly competitive cystic fibrosis trials
File(s)Who and why docx.pdf (467.33 KB)
Accepted version
Author(s)
Dobra, Rebecca
Scott, Sandra
Davies, Jane C
Simmonds, Nicholas J
Type
Journal Article
Date Issued
2019-09
Date Acceptance
2019-04-05
Citation
Journal of Cystic Fibrosis, 2019, 18 (5), pp.e45-e46
ISSN
1569-1993
Publisher
Elsevier
Start Page
e45
End Page
e46
Journal / Book Title
Journal of Cystic Fibrosis
Volume
18
Issue
5
Copyright Statement
© 2019 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved. This manuscript is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Licence http://creativecommons.org/licenses/by-nc-nd/4.0/
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/31060801
PII: S1569-1993(19)30068-2
Subjects
1103 Clinical Sciences
Respiratory System
Publication Status
Published
Coverage Spatial
Netherlands
Date Publish Online
2019-05-03